JL

Jennifer Levin Carter

Precision Medicine Management At Scale

Boston, Massachusetts

Invests in

  • Min Investment:

    $1,000,000.00
  • Max Investment:

    $20,000,000.00
  • Target Investment:

    $10,500,000.00

Work Experience

2023

  • Founder and CEO

    2023

    Medzown is Precision Medicine Management at Scale. We use advanced analytics and deep expertise to bridge the gap between patients and treatments like immunotherapies, targeted therapies, cell and gene therapies, and clinical trials. At the same time, we deliver exceptional return on investment for payers, providers, and pharma.

  • Founder and CEO

    2023

  • Venture Partner

    2021

    Sandbox invests in technologies that drive lasting change in human livelihood and transform healthcare, sustainability and insurance & financial services. Sandbox also provides innovation consulting through Sandbox Advisors. Sandbox Clinical Ventures focuses on accelerating clinical innovation by investing in companies with transformative diagnostic, device and lab technologies. We bring together key stakeholders across the strategic and investment landscape to back companies that can improve the health of populations, reimagine the experience of care, and bend the cost curve.

  • Senior Strategic Advisor

    2020

  • Co-founder, Board Member

    2019

  • Board of Directors

    2018

  • Member, Directors Advisory Board

    2013

  • Board Member, Board Of Directors

    2020 - 2023

2021 - 2023

  • Managing Director

    2021 - 2023

    The Blue Venture Fund is a unique collaboration among Blue Cross Blue Shield (BCBS) companies, the Blue Cross Blue Shield Association (BCBSA), and Sandbox, to which thirty-five BCBS companies have committed approximately $900 million across four funds. The Blue Venture Fund invests in promising emerging companies of strategic relevance to Blue Cross and/or Blue Shield companies and provides the portfolio with access to BCBS companies to deploy innovation at scale.  Sandbox is an independent company that provides healthcare-related investment management exclusively for the Blue Venture Fund.

2020 - 2022

  • Board Member and Senior Advisor

    2020 - 2022

    Acquired by InTandem